QIAGEN IPA
Identifying novel drug targets in paraganglioma
111 views
If you'd like to explore a new way to identify potential new drug targets, you won't want to miss this unique opportunity to learn from industry experts about:
How ML used known relationships in the QKG to infer hidden relationships between potential targets and diseases
A library of 1500 disease networks available in QIAGEN Ingenuity Pathway Analysis (IPA)
MicroMatrices' research into paraganglioma and evaluation of novel gene associations predicted by our disease network
Opportunities to verify new drug targets for paraganglioma as well as potential targets in other diseases
Related videos
QIAGEN IPA
Multi-omics (metabolomics, proteomics, transcriptomics) analysis using QIAGEN Ingenuity Pathway...
This 90-minute training session is about how QIAGEN Ingenuity Pathway...
QIAGEN IPA
Single cell RNA-seq – data upload & analysis in Ingenuity Pathway Analysis (IPA)
This training is generated based on feedback from recent “Single Cell...
QIAGEN IPA
Introduction to Analysis Match in IPA - Compare your gene and protein expression data to over...
With all the expression datasets that are available to the public, wouldn’t...
QIAGEN IPA
IPA deeper dive: Making most out of user’s core/expression analysis and new features
Many of you who use QIAGEN Ingenuity Pathway Analysis (IPA) have requested a...